-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: September 13, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Chronic Venous Ulcers:
A Comparative Effectiveness Review of Treatment Modalities
Amendment D…
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - DEMENTIA INCLUDING ALZHEIMER'S #04
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 04: Dementia (Including Alzheimer’s
Disease)
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - limitations, including low adherence to treatment recommendations and medication diversion,
which can lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
November 01, 2012 - Development Team
Topic nomination development is typically conducted by a small team consisting of a team
lead … The team lead is often a doctorally-
trained person with a strong epidemiology, health services research … A poorly defined PICO can lead to development of a topic that may miss important
populations, lack … A vague PICO also presents scoping challenges and may lead to a review that is too inclusive
or too
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - Reviewer 3 ES: Treatment safety is
defined by the rates of
adverse effects that lead to
treatment … follows:
“Treatment safety is defined by the total rates
of adverse effects and adverse effects that
lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Slowing disease progression could lead to improved quality of life and reduced
costs. … Slowed disease progression could
lead to improved patient quality of life and reduced costs. … COPD exacerbations can lead to significant
declines in lung function and progression towards respiratory
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - 1
Comparative Effectiveness Review
Number 134
Pharmacotherapy for Adults With Alcohol-Use
Disorders in Outpatient Settings
Executive Summary
Background
Alcohol misuse, or unhealthful alcohol
use, which includes the full spectrum
from drinking above recommended
limits (i.e., risky/hazardous drinking) to
alcoho…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-pregnant-protocol.pdf
August 24, 2023 - 17-19 and have a greater frequency of
missed well-baby check-ups.20 Postpartum depression may also lead … restriction will reduce the
need to spend resources on extracting and summarizing studies that will only lead … restriction will
reduce the need to spend
resources on extracting
and summarizing studies
that will only lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_policymaker.pdf
August 01, 2016 - Transitional Care Interventions To Prevent Readmissions for People With Heart Failure
B A C K G R O U N D
Heart failure (HF) is a major clinical and public
health problem and a leading cause of hospitalization
and health care costs in the United States. Despite a
decline in HF-related hospitalizations during the …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - For
example, choosing to remove or destroy a low-grade prostatic malignancy can lead to
complications … tests are often referred to as tests for publication bias; reasons
other than publication bias can lead … The following team members will be involved:
• The EPC director
• The EPC co-director
• 1 Project Lead … • 1 Co-project lead/Research Associate
• 1 Local Clinical Expert
• 1 Project manager
24
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - Simply omitting trials with data that
are MNAR will lead to biased results.
26
Missing Summary … We recommend that studies
missing only SDs should not be excluded, as this could lead to a biased combined … Studies missing only SDs should not
be excluded as this may lead to a biased combined estimate when … Direct substitution
using the largest SD is the simplest method and the most likely to lead to a conservative … However, if one is comfortable with
one of the more complex methods, using it may lead to a more accurate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - between
diagnostic tests depend on patient or specimen
characteristics or the clinical scenarios that lead … toxigenic C. difficile using Bayes’ formula, then the
differences in post-test probabilities might not lead … Failures with vapor
disinfection systems would be possible and might lead
to toxic exposures of personnel … that detect genetic residue related to C. difficile
toxin production rather than the toxins per se lead
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Cervical DDD occurs when progressive changes in
the cervical vertebral discs lead to loss of disc height … This may lead to different outcomes among treatment
centers. … MSCs are purported to lead to cartilage regeneration because of the secretion of
growth factors by … outcomes: Multilevel DDD presents a significant unmet need for new
treatment options because ACDF can lead … However, the mechanism by which these cells lead to cartilage
generation is still unclear.33 MSCs may
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
November 01, 2012 - neuropsychiatric
and hematologic adverse effects.23 Such adverse effects
can be difficult to tolerate and can lead … regimen recommended by the
FDA for antiviral-naïve patients with cirrhosis (4 weeks of
dual therapy lead-in … regimens,
shorter fixed duration triple therapy boceprevir therapy,
and boceprevir without dual therapy lead-in … virologic
response
Two trials of triple therapy with boceprevir for 48 weeks
(4 weeks of dual therapy lead-in … regimens on clinical outcomes in randomized
trials or cohort studies is a challenge due to the long
lead
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-disposition-comments.pdf
March 25, 2024 - We agree
and policy implications, which lead to harm for people that underscoring potential
with ADHD … Thus, this is incredibly
misleading and will lead to significant problems and
false belief that we … Yes, again, substance use is awful
and can lead to mortality, but so can untreated ADHD. … Misdiagnosis of
ADHD not only leads to its
overdiagnosis or
underdiagnosis, but it can
also can lead
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Lead investigator, senior scientist, research fellow identified
Step 3: Selected team performs general … In the human growth hormone project, the core leadership team identified the lead investigator, senior … Doing so might lead to a perception of what the ultimate project results might be, and then the methods
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth-covid-19-disposition-comments.pdf
January 03, 2023 - for CF, the Cystic Fibrosis
Foundation’s mission is to give all people with CF the opportunity to lead
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
September 20, 2013 - cognition and language have
led to the suggestion that beginning intensive therapy at an earlier age may lead … Individuals engage in interventions, which
may lead to specific outcomes (KQ 1). … exclude case series, as additional
case series (studies without a comparison group) are unlikely to lead
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - Layout 1
Background
Almost 75 million American adults—
approximately one-third—have
hypertension. The prevalence of
hypertension increases with advancing age
such that more than half of people 55 to 74
years old and approximately three-fourths
of those age 75 years and older are
affected. In addition to being the pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/facilitation-webcast-slides.pptx
June 13, 2013 - the process for training facilitators.
22
Structured Facilitator Guide
Activity, objective, time, lead